-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LMFy0UaAulEbQsYKtvMCbXHt26CgMtZWsl/u3gvNYhK9m8kw9ZshA1cX5fAfGaJv RXSj2w/eZS8fhRplaVbwIw== 0001158833-05-000012.txt : 20050615 0001158833-05-000012.hdr.sgml : 20050614 20050615162530 ACCESSION NUMBER: 0001158833-05-000012 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050615 DATE AS OF CHANGE: 20050615 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIFE SCIENCES RESEARCH INC CENTRAL INDEX KEY: 0001158833 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 522340150 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-62457 FILM NUMBER: 05897807 BUSINESS ADDRESS: STREET 1: P. O. BOX 2360 STREET 2: METTLERS ROAD CITY: EAST MILLSTONE STATE: NJ ZIP: 08875 BUSINESS PHONE: 732-649-9961 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BAKER ANDREW H CENTRAL INDEX KEY: 0001037414 STATE OF INCORPORATION: MD FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: BUSINESS PHONE: 732-873-2550 MAIL ADDRESS: STREET 1: METTLERS ROAD STREET 2: P. O. BOX 2360 CITY: EAST MILLSTONE STATE: NJ ZIP: 08875 SC 13D/A 1 sched13dahbamend4.txt FORM 13D A4 SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No.4 )(1) Life Sciences Research, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Voting Common Stock, $.01 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 5321691090 - -------------------------------------------------------------------------------- (CUSIP Number) Andrew H. Baker Life Sciences Research, Inc. P. O. Box 2360 Mettlers Road East Millstone, NJ 08875 (732) 873-2550 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 14, 2005 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [_]. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. (Continued on following pages) - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (SC13D-07/99) CUSIP No.5321691090 13D/A ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Andrew H. Baker ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* Not applicable. ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION United Kingdom ________________________________________________________________________________ 7 SOLE VOTING POWER 2,311,060 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 0 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 236,583 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 2,074,477 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,311,060 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* Not applicable [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 17.6% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* IN ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No.5321691090 13D/A ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Focused Healthcare Partners, LLC ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [x] ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* Not applicable. ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION New Jersey ________________________________________________________________________________ 7 SOLE VOTING POWER 1,874,477 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 0 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 0 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 1,874,477 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,874,477 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 14.3% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* CO ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 5321691090 13D/A ________________________________________________________________________________ Item 1. Security and Issuer. Class of Securities: Voting Common Stock, $.01 par value per share (the "Common Stock") Issuer: Life Sciences Research, Inc. (the "Issuer" or the "Company"), P.O. Box 2360, Mettlers Road, East Millstone, NJ 08875 ________________________________________________________________________________ Item 2. Identity and Background. (a) Names: Andrew H. Baker ("Baker") Focused Healthcare Partners, LLC ("FHP LLC") (b) Business Address: Andrew H. Baker c/o Life Sciences Research, Inc. P.O. Box 2360, Mettlers Road East Millstone, NJ 08875 Focused Healthcare Partners, LLC c/o Life Sciences Research, Inc. P. O. Box 2360, Mettlers Road East Millstone, NJ 08875 (c) Principal Occupation or Employment: Baker: Chairman and CEO of the Issuer FHP LLC: Investments (d) Criminal Convictions: None. (e) Civil Adjudication of Violation of Securities Laws: None. (f) Citizenship: Baker: United Kingdom citizen FHP LLC New Jersey limited liability company ________________________________________________________________________________ Item 3. Source and Amount of Funds or Other Consideration. Not applicable. ________________________________________________________________________________ Item 4. Purpose of Transaction. (a)-(j) This filing is being made to report the pledge as of June 14, 2005 (the "Pledge") to Lamgrove Investments Limited ("Lender") by Baker and FHP LLC of the beneficial ownership of an aggregate of 2,074,477 shares of LSR common stock as security for a loan taken by an affiliate of Baker from such Lender in connection with such affiliate's purchase from and leaseback to the Company of the Company's three operating properties. Pursuant to such Pledge, Baker and FHP LLC retain voting rights over such shares but are not free to dispose of such shares without the consent of the Lender. Of such pledged shares, 200,000 are deemed to be beneficially owned by Baker by virtue of stock option agreements he has entered into with the Company and 1,874,477 are deemed to be beneficially owned by FHP LLC (410,914 pursuant to a warrant agreement with the Company and the remainder through direct share ownership). ________________________________________________________________________________ Item 5. Interest in Securities of the Issuer. (a) Beneficial Ownership by the Reporting Persons: Number of Shares ---------------- Baker: Aggregate number of shares: 2,311,060 Percentage: 17.6% FHP LLC: Aggregate number of shares: 1,874,477 Percentage 14.2% All of the above percentages are calculated on the basis of 12,523,301 outstanding shares of Common Stock, as reported in the Company's Form 10-Q for the quarter ended March 31, 2005, plus 410,914 shares subject to a presently exercisable warrant held by FHP LLC to purchase 410,914 shares of Common Stock and 200,000 shares subject to a presently exercisable option to purchase 200,000 shares of Common Stock held by Baker, being deemed outstanding. (b) Baker: Sole Voting Power: 2,311,060 Shared Voting Power: 0 Sole Dispositive Power: 0 Shared Dispositive Power: 2,311,060 FHP LLC: Sole Voting Power: 1,874,477 Shared Voting Power: 0 Sole Dispositive Power: 0 Shares Dispositive Power: 1,874,477 (c) Effective as of June 14, 2005, Baker and FHP LLC effected the Pledge. See Item 4 above. (d) Not applicable. (e) Not applicable. ________________________________________________________________________________ Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. Effective as of June 14, 2005, Baker and FHP LLC effected the Pledge. See Item 4 above. ________________________________________________________________________________ Item 7. Material to be Filed as Exhibits. None. ________________________________________________________________________________ SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. June 15, 2005 ---------------------------------------- (Date) /s/ Andrew H. Baker ---------------------------------------- (Signature) Andrew H. Baker ---------------------------------------- (Name/Title) Focused Healthcare Partners LLC /s/ Andrew H. Baker By: ----------------------------------- Name: Andrew H. Baker Title: Member Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). EDGARLink 7.0 (8/00) Ver. 3.1 -----END PRIVACY-ENHANCED MESSAGE-----